|
End-of-day quote
Shenzhen S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 8.490 CNY | -3.52% |
|
+5.60% | -1.74% |
| Market Cap | 4.34B 643M 555M 522M 474M 892M 61.47B 907M 6.11B 2.39B 30.78B 2.41B 2.36B 102B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.86B 572M 494M 464M 422M 793M 54.68B 807M 5.44B 2.13B 27.38B 2.15B 2.1B 90.99B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
34.06% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | -3.52% | ||
| 1 week | +5.60% | ||
| Current month | +9.97% | ||
| 1 month | +6.39% | ||
| 3 months | +8.15% | ||
| 6 months | -5.25% | ||
| Current year | -1.74% |
| 1 week | 7.89 | 8.95 | |
| 1 month | 7.41 | 8.95 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.02 | |
| 3 years | 5.84 | 11.85 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 2022-04-05 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 2022-12-01 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 2018-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Bo Su
CHM | Chairman | 60 | 2014-05-07 |
Ai Guo Shi
CHM | Chairman | 62 | 2017-06-29 |
Zhi Jun Liu
BRD | Director/Board Member | 54 | 2016-04-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.52% | +5.60% | -8.61% | -24.67% | 643M | ||
| -0.85% | -1.44% | -10.60% | -6.56% | 13.24B | ||
| -1.45% | -2.24% | -32.41% | -57.57% | 4.98B | ||
| -1.44% | -2.77% | +3.16% | -2.37% | 4.91B | ||
| -0.82% | -0.18% | +6.80% | -28.38% | 4.2B | ||
| -1.69% | -2.72% | -18.35% | +0.61% | 3.59B | ||
| -0.65% | -2.48% | -5.25% | +13.64% | 3.4B | ||
| -1.96% | -5.37% | -7.58% | -8.06% | 3.35B | ||
| -0.56% | -0.25% | -13.63% | -16.53% | 2.49B | ||
| +2.56% | +10.60% | +3.45% | -10.45% | 1.81B | ||
| Average | -1.04% | -0.27% | -8.30% | -14.03% | 4.26B | |
| Weighted average by Cap. | -1.01% | -1.70% | -9.39% | -13.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 145M 126M 118M 107M 202M 13.9B 205M 1.38B 540M 6.96B 546M 534M 23.13B | 916M 136M 117M 110M 100M 188M 12.98B 191M 1.29B 505M 6.5B 510M 499M 21.6B |
| Net income | 60.07M 8.91M 7.69M 7.23M 6.57M 12.36M 852M 12.56M 84.7M 33.12M 426M 33.44M 32.71M 1.42B | 49.21M 7.3M 6.3M 5.92M 5.39M 10.12M 698M 10.29M 69.38M 27.13M 349M 27.39M 26.8M 1.16B |
| Net Debt | -357M -52.95M -45.73M -42.97M -39.08M -73.47M -5.06B -74.69M -504M -197M -2.54B -199M -194M -8.43B | -479M -71.02M -61.34M -57.64M -52.42M -98.56M -6.79B -100M -675M -264M -3.4B -267M -261M -11.3B |
Employees
1,332
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | CN¥8.490 | -3.52% | 37,512,058 |
| 26-08-13 | CN¥8.800 | +10.00% | 25,700,955 |
| 26-08-12 | CN¥8.000 | 0.00% | 2,957,600 |
| 26-08-11 | CN¥8.000 | -1.11% | 3,177,850 |
| 26-08-10 | CN¥8.090 | +0.62% | 4,673,550 |
- Stock Market
- Stocks
- 002644 Stock
Select your edition
All financial news and data tailored to specific country editions
















